Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions

NCT05552495 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension and Dyslipidemia

Interventions

DRUG: CKD-386(4) F1
DRUG: CKD-386(4) F2
DRUG: D013, D326, D337

Sponsor

Chong Kun Dang Pharmaceutical